Prescription drug transparency provisions modified.
2025-2026
Introduced by
Robert Bierman,
HF 3054 mandates 340B entities in Minnesota to report drug costs and payments annually, enhancing transparency and accountability in prescription drug pricing.
Introduction and first reading, referred to Health Finance and Policy
#drugsandmedicine
#healthandhealthdepartment
